With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.
Characterising reduced NPY/AgRP upregulation and attenuated food intake responses following Ipamorelin versus non-selective GH secretagogue administration
The most significant clinical data on retatrutide to date come from a Phase 2 randomised controlled trial published in the New England Journal of Medicine (Jastreboff et al., 2023) , which evaluated the medicine in adults with obesity (BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity) but without type 2 diabetes
Does indoor cyclings calorie-burning role in weight management still apply when used alongside weight-loss drugs
His company, Mark Cuban Cost Plus Drugs, intends to be a cheaper and more transparent alternative to traditional PBMs